Cargando…

A Nationwide Study of Campylobacter jejuni and Campylobacter coli Bacteremia in Finland Over a 10-Year Period, 1998–2007, With Special Reference to Clinical Characteristics and Antimicrobial Susceptibility

Background. Campylobacter bacteremia is an uncommon condition, usually diagnosed in elderly and immunocompromised patients. Methods. Blood culture isolates and clinical information were collected for patients with diagnoses of Campylobacter jejuni or Campylobacter coli bacteremia in Finland from 199...

Descripción completa

Detalles Bibliográficos
Autores principales: Feodoroff, Benjamin, Lauhio, Anneli, Ellström, Patrik, Rautelin, Hilpi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174097/
https://www.ncbi.nlm.nih.gov/pubmed/21921217
http://dx.doi.org/10.1093/cid/cir509
_version_ 1782212026748108800
author Feodoroff, Benjamin
Lauhio, Anneli
Ellström, Patrik
Rautelin, Hilpi
author_facet Feodoroff, Benjamin
Lauhio, Anneli
Ellström, Patrik
Rautelin, Hilpi
author_sort Feodoroff, Benjamin
collection PubMed
description Background. Campylobacter bacteremia is an uncommon condition, usually diagnosed in elderly and immunocompromised patients. Methods. Blood culture isolates and clinical information were collected for patients with diagnoses of Campylobacter jejuni or Campylobacter coli bacteremia in Finland from 1998 through 2007. Bacterial species were identified by means of polymerase chain reaction analysis, and minimal inhibitory concentrations for ciprofloxacin, clindamycin, doxycycline, erythromycin, gentamicin, meropenem, and metronidazole were determined with an agar dilution method. Medical records and mortality data within 1 year after the bacteremic episode were reviewed. Results. The study included 76 patients (median age, 46 years), for whom bacterial isolates (C. jejuni in 73, C. coli in 3) and clinical information were available. Most patients (70%) had no significant underlying diseases. The majority (82%) of the isolates were susceptible for all antimicrobial agents tested. However, antimicrobial therapy seemed to have only a limited effect, because no differences could be detected between patients with appropriate empirical antimicrobial treatment and those with delayed appropriate, inappropriate, or no antimicrobial therapy, either in the duration of hospitalization (median, 4 days for both groups) or in attributable mortality. The outcome of the infection was severe in 4 patients infected with C. jejuni; 2 died within 30 days, spondylodiscitis developed in 1, and Guillain-Barré syndrome developed in 1. Conclusions. C. jejuni and C. coli bacteremia occurred mainly in moderately young individuals without severe underlying diseases. The bacterial isolates were predominantly susceptible to antimicrobial agents, and the outcome of the disease was typically good, regardless of appropriate or inappropriate antimicrobial treatment given in the hospital.
format Online
Article
Text
id pubmed-3174097
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-31740972011-10-15 A Nationwide Study of Campylobacter jejuni and Campylobacter coli Bacteremia in Finland Over a 10-Year Period, 1998–2007, With Special Reference to Clinical Characteristics and Antimicrobial Susceptibility Feodoroff, Benjamin Lauhio, Anneli Ellström, Patrik Rautelin, Hilpi Clin Infect Dis Electronic Articles Background. Campylobacter bacteremia is an uncommon condition, usually diagnosed in elderly and immunocompromised patients. Methods. Blood culture isolates and clinical information were collected for patients with diagnoses of Campylobacter jejuni or Campylobacter coli bacteremia in Finland from 1998 through 2007. Bacterial species were identified by means of polymerase chain reaction analysis, and minimal inhibitory concentrations for ciprofloxacin, clindamycin, doxycycline, erythromycin, gentamicin, meropenem, and metronidazole were determined with an agar dilution method. Medical records and mortality data within 1 year after the bacteremic episode were reviewed. Results. The study included 76 patients (median age, 46 years), for whom bacterial isolates (C. jejuni in 73, C. coli in 3) and clinical information were available. Most patients (70%) had no significant underlying diseases. The majority (82%) of the isolates were susceptible for all antimicrobial agents tested. However, antimicrobial therapy seemed to have only a limited effect, because no differences could be detected between patients with appropriate empirical antimicrobial treatment and those with delayed appropriate, inappropriate, or no antimicrobial therapy, either in the duration of hospitalization (median, 4 days for both groups) or in attributable mortality. The outcome of the infection was severe in 4 patients infected with C. jejuni; 2 died within 30 days, spondylodiscitis developed in 1, and Guillain-Barré syndrome developed in 1. Conclusions. C. jejuni and C. coli bacteremia occurred mainly in moderately young individuals without severe underlying diseases. The bacterial isolates were predominantly susceptible to antimicrobial agents, and the outcome of the disease was typically good, regardless of appropriate or inappropriate antimicrobial treatment given in the hospital. Oxford University Press 2011-10-15 /pmc/articles/PMC3174097/ /pubmed/21921217 http://dx.doi.org/10.1093/cid/cir509 Text en © The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please email:journals.permissions@oup.com. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Electronic Articles
Feodoroff, Benjamin
Lauhio, Anneli
Ellström, Patrik
Rautelin, Hilpi
A Nationwide Study of Campylobacter jejuni and Campylobacter coli Bacteremia in Finland Over a 10-Year Period, 1998–2007, With Special Reference to Clinical Characteristics and Antimicrobial Susceptibility
title A Nationwide Study of Campylobacter jejuni and Campylobacter coli Bacteremia in Finland Over a 10-Year Period, 1998–2007, With Special Reference to Clinical Characteristics and Antimicrobial Susceptibility
title_full A Nationwide Study of Campylobacter jejuni and Campylobacter coli Bacteremia in Finland Over a 10-Year Period, 1998–2007, With Special Reference to Clinical Characteristics and Antimicrobial Susceptibility
title_fullStr A Nationwide Study of Campylobacter jejuni and Campylobacter coli Bacteremia in Finland Over a 10-Year Period, 1998–2007, With Special Reference to Clinical Characteristics and Antimicrobial Susceptibility
title_full_unstemmed A Nationwide Study of Campylobacter jejuni and Campylobacter coli Bacteremia in Finland Over a 10-Year Period, 1998–2007, With Special Reference to Clinical Characteristics and Antimicrobial Susceptibility
title_short A Nationwide Study of Campylobacter jejuni and Campylobacter coli Bacteremia in Finland Over a 10-Year Period, 1998–2007, With Special Reference to Clinical Characteristics and Antimicrobial Susceptibility
title_sort nationwide study of campylobacter jejuni and campylobacter coli bacteremia in finland over a 10-year period, 1998–2007, with special reference to clinical characteristics and antimicrobial susceptibility
topic Electronic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3174097/
https://www.ncbi.nlm.nih.gov/pubmed/21921217
http://dx.doi.org/10.1093/cid/cir509
work_keys_str_mv AT feodoroffbenjamin anationwidestudyofcampylobacterjejuniandcampylobactercolibacteremiainfinlandovera10yearperiod19982007withspecialreferencetoclinicalcharacteristicsandantimicrobialsusceptibility
AT lauhioanneli anationwidestudyofcampylobacterjejuniandcampylobactercolibacteremiainfinlandovera10yearperiod19982007withspecialreferencetoclinicalcharacteristicsandantimicrobialsusceptibility
AT ellstrompatrik anationwidestudyofcampylobacterjejuniandcampylobactercolibacteremiainfinlandovera10yearperiod19982007withspecialreferencetoclinicalcharacteristicsandantimicrobialsusceptibility
AT rautelinhilpi anationwidestudyofcampylobacterjejuniandcampylobactercolibacteremiainfinlandovera10yearperiod19982007withspecialreferencetoclinicalcharacteristicsandantimicrobialsusceptibility
AT feodoroffbenjamin nationwidestudyofcampylobacterjejuniandcampylobactercolibacteremiainfinlandovera10yearperiod19982007withspecialreferencetoclinicalcharacteristicsandantimicrobialsusceptibility
AT lauhioanneli nationwidestudyofcampylobacterjejuniandcampylobactercolibacteremiainfinlandovera10yearperiod19982007withspecialreferencetoclinicalcharacteristicsandantimicrobialsusceptibility
AT ellstrompatrik nationwidestudyofcampylobacterjejuniandcampylobactercolibacteremiainfinlandovera10yearperiod19982007withspecialreferencetoclinicalcharacteristicsandantimicrobialsusceptibility
AT rautelinhilpi nationwidestudyofcampylobacterjejuniandcampylobactercolibacteremiainfinlandovera10yearperiod19982007withspecialreferencetoclinicalcharacteristicsandantimicrobialsusceptibility